ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that the Company’s Board of Directors has appointed Russell Skibsted to the position of Chief Financial Officer, succeeding Robert Peabody. Mr. Russell Skibsted brings over 25 years of financial management […]
NEW YORK – Germany’s Merck KGaA today announced the completion of its $17 billion acquisition of Sigma-Aldrich, following approval from the European Commission. The deal creates a science sector giant that will “cover every step of the biotech production chain,” Merck said in a statement. The company will have around 50,000 employees in 67 countries, […]
Göteborg, Sweden, Takara Bio Europe AB, a wholly-owned subsidiary of Takara Bio Inc., announced today that it is launching the Cellartis iPS Cell to Hepatocyte Differentiation System and related ancillary products. This system provides a complete solution for directed differentiation of disease-specific or patient-specific human inducible pluripotent stem (hiPS) cells to hepatocytes by combining a […]
Information Regarding the Sale of “ReproHP Medium,” a Culture Fluid for Human Primary Liver Cells with High Levels of Functionality “ReproHP Medium,” a highly functional culture fluid for human primary liver cells developed in conjunction with the National Cancer Center, is set to go on sale in December this year. Our company, in conjunction with […]
Abcam offers direct service to Singapore as part of deepening commitment to Asia-Pacific researchers
Cambridge, UK: Abcam plc, a global leader in the supply of life science research tools, announced today the launch of its direct service to Singapore, as part of a global commitment to support local researchers’ needs. The new Singapore service will provide direct technical support and customer services, expanding Abcam’s presence in the Asia-Pacific region. […]
CINCINNATI — Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) announced that it has made a minority investment in Oasis Diagnostics® Corporation (“Oasis”), with the right to acquire Oasis in the future. The terms of the transaction were not disclosed. Oasis designs, develops, manufactures and sells pre-analytic tools for the collection, preservation, and transportation of saliva/oral […]
Stockholm – IFS, the global enterprise applications company, announces that Sartorius AG — a leading pharmaceutical and laboratory equipment supplier—will implement IFS Field Service Management™ at 50 sites worldwide. The software is a core part of the Enterprise Service Management offering. The agreement includes licenses and services worth more than 1.5 million euros. Following a […]
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, today announces that it has entered into a definitive agreement to acquire the entire issued share capital of AxioMx, Inc. (“AxioMx”) (“Acquisition”) on a cash-free/debt-free basis for $20m upfront with further performance-based payments totalling $25m. These performance payments […]
Darmstadt, Germany – Merck announced that following the final approval of the European Commission it is set to complete its $17 billion (€13.1 billion) acquisition of Sigma-Aldrich. The European Commission had granted conditional approval to the acquisition of Sigma-Aldrich on June 15, 2015, subject to the divestment of certain Sigma-Aldrich assets. On Oct. 20, 2015, […]
CORALVILLE, IA – Integrated DNA Technologies (IDT), introduces its new xGen® Exome Research Panel v1.0 for insightful analysis of the human exome via next generation sequencing. A total of 429,826 probes span 39 Mb of the human genome, providing deep and uniform coverage of 19,396 genes. This leads scientists directly to relevant mutations, aiding advances […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
